Safe and effective treatment with daclatasvir and asunaprevir in a liver transplant recipient with severe cholestatic hepatitis C.

Safe and effective treatment with daclatasvir and asunaprevir in a liver transplant recipient with severe cholestatic hepatitis C.

Item
http://www.wikidata.org/entity/Q41470523
Selection Criteria and Current Issues in Liver Transplantation for Hepatocellular CarcinomaSevere Cholestatic Hepatitis C in Transplant Recipients: No Longer a Threat to Graft Survival.Successful Management of Graft Reinfection of HCV Genotype 2 in Living Donor Liver Transplantation from a Hepatitis B Core Antibody-Positive Donor with Sofosbuvir and Ribavirin.Daclatasvir: A NS5A Replication Complex Inhibitor for Hepatitis C Infection.Three patients treated with sofosbuvir plus ledipasvir for recurrent hepatitis C after liver transplantation.Outcomes of treatment with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation.Validation of the FIB-4 index for evaluation of fibrosis in patients with recurrent hepatitis C after living donor liver transplantation: A single center experience.
P2860

Safe and effective treatment with daclatasvir and asunaprevir in a liver transplant recipient with severe cholestatic hepatitis C.

Item
http://www.wikidata.org/entity/Q41470523
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safe and effective treatment w ...... evere cholestatic hepatitis C.
@en
type
label
Safe and effective treatment w ...... evere cholestatic hepatitis C.
@en
prefLabel
Safe and effective treatment w ...... evere cholestatic hepatitis C.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Safe and effective treatment w ...... evere cholestatic hepatitis C.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698